from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1881c/lppE

LFCtreatmentdescriptionclass of inhibitor

0.686

Amikacinug/mL Amikacintranslation

-0.335

Cap5-10ug/mL Capreomycintranslation

0.619

Rox10-50 ug/mL Roxithromycintranslation

-0.668

SM2-5 ug/mL Streptomycintranslation

2.223

Tet5-10 ug/mL Tetracyclinetranslation

0.537

Rif0.2-5ug/mL Rifampicintranscription

0.227

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.882

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.569

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.746

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.039

Clofazimine10-13 ug/mL Clofaziminerespiration

0.522

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.305

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.850

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.515

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.380

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.017

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.171

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.461

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.782

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.191

KCN5-20 ug/mL Potassium cyaniderespiration

0.636

NaN30.2-2 mM Sodium aziderespiration

0.818

Nigericin50 uM Nigericinrespiration

0.096

TRC10-150 ug/mL Triclosanrespiration

-0.943

TRZ10-25 ug/mL Thioridazinerespiration

0.087

Valinomycin0.5-10 uM Valinomycinrespiration

2.245

ZnSO42 mM ZnSO4respiration

-1.806

menadione6-10 ug/mL Menadionerespiration

-0.549

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.064

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.156

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.571

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.455

NRP_1Non-replicating persistence stage 1dosRassociated

-0.314

Amp0.2mg/mL AmpicillincellWall

-0.241

Cephalexin20-100 ug/mL CephalexincellWall

-0.595

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.369

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.525

EMB10-20 ug/mL EthambutolcellWall

1.589

Eta12-40 ug/mL EthionamidecellWall

-0.249

INH0.2-0.4 ug/mL IsoniazidcellWall

0.469

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.739

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.613

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.411

BZA0.12 mg/mL BenzamidearomaticAmides

-0.429

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.077

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.141

H2O24 mM hydrogen peroxideDNAdamaging

-0.276

Levo10 ug/mL LevofloxacinDNAdamaging

-0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.404

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.248

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.279

UVUV-irradiationDNAdamaging

-0.431

ARP41-4 ug/mL Antitubercular compound ARP4?

0.147

Antimycin12.5-50 ug/mL Antimycin A?

0.228

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.085

PA_110-50 ug/mL Antitubercular compound PA-1?

0.218

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.005

PA8240.2-2 ug/mL PA-824?

-0.306

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.394

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.333

Verapamil50 uM Verapamil?

0.596

mercaptoethanol2 mM 2-Mercaptoethanol?

0.048

methoxatin10-20 ug/mL Methoxatin?